Investor Resources Home

Webcast ImageWebcast - Live
Heron Therapeutics Inc at Bank of America Merrill Lynch 2016 Health Care Conference
05/10/16 at 10:00 a.m. PT
At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents. Our goal is to build on therapeutics with well-known pharmacology by improving their safety and efficacy as well as broadening their potential field of use.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$19.80
Change (%)0.00 (0.00%)
Volume0
Data as of 05/04/16 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
03/07/16
Download Documentation Corporate Presentation March 2016

Recent News

More >>
DateTitle 
04/18/16Heron Therapeutics Provides Update on FDA Review of SUSTOL® NDAPrinter Friendly Version
03/17/16Heron Therapeutics Appoints David L. Szekeres, SVP Business Development, General Counsel and Corporate SecretaryPrinter Friendly Version
03/03/16Heron Therapeutics Provides Update on SUSTOL® NDA Printer Friendly Version
02/29/16Heron Therapeutics Provides Update on SUSTOL® NDAPrinter Friendly Version

Upcoming Events

More >>
DateTitle
05/10/16 10:00 a.m. PT
Heron Therapeutics Inc at Bank of America Merrill Lynch 2016 Health Care Conference
LocationLas Vegas, NV
Data provided by NASDAQ. Minimum 15 minutes delayed.